Overview

• Dr Dangs Lab launched Dendrite Dx, combining a 15–20 minute digital cognitive assessment with blood biomarkers (including p‑tau217 and Aβ1‑42) and ApoE genotyping, followed by confirmatory PrecivityAD2 Amyloid Probability Score 2 via a C2N Diagnostics collaboration.
• WHO and ADI estimate about 55 million people live with dementia globally, projecting 78 million by 2030 and 139 million by 2050, while recent Indian research counts roughly 8.8 million Indians aged 60+ today and nearly 16.9 million by 2036 if prevalence remains unchanged.
• Commercial data indicate Mumbai now accounts for about 33% of India’s dementia‑care users, with demand in the city growing at more than 100% CAGR over the past three years, ahead of Hyderabad, Bengaluru and the NCR.
• Clinicians highlight limited system capacity with roughly 100 memory clinics nationwide and report high caregiver strain, citing an AIIMS finding that nearly 75% of caregivers face significant financial, emotional and social stress.
• Experts urge earlier evaluation based on persistent warning signs and emphasize risk reduction through controlling hypertension and diabetes, regular physical activity, better sleep, reduced smoking and alcohol, and sustained social and cognitive engagement.